Archives for: September 20th, 2016

CorMedix Inc. to Present at Multiple Investor and Industry Conferences

Written by Janine McCargo on September 20, 2016

Bedminster, NJ –September 20, 2016 – CorMedix Inc. (NYSE MKT:…

CorMedix Inc. Announces Signing of an Agreement with POETIC (Pediatric Oncology Experimental Therapeutics Investigators Consortium), to Develop CRMD-005, a Proprietary Formulation of Taurolidine, for Rare Orphan Pediatric Tumors

Written by cormedixadmin on September 15, 2016

Bedminster, NJ – September 15, 2016 – CorMedix Inc. (NYSE…

CorMedix Inc. to Present at 2016 Rodman & Renshaw 18th Annual Global Investment Conference

Written by cormedixadmin on September 6, 2016

Bedminster, NJ –September 6, 2016 – CorMedix Inc. (NYSE MKT:…